Anthropic says its Claude AI system autonomously identified a previously uncharacterized enzyme system resembling CRISPR, a gene-editing technology. The company has not established what the newly identified system does. Anthropic CEO Dario Amodei acknowledged that its biological function remains unknown. The disclosure underscores both the potential and the limits of AI-assisted scientific discovery: Claude was able to identify a notable pattern in DNA, but human researchers still do not know how to interpret or use the finding. Anthropic’s announcement, reported by Decrypt, did not provide additional details about the system’s structure, applications or practical impact. For now, the development represents an unidentified biological discovery rather than a confirmed breakthrough with a defined use.
